Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §5

CEI-MS-01 — system suitability and acceptance criteria

The performance the system must demonstrate, and the criteria a result must meet to be reportable.

Document identifier
CEI-MS-01/5
Series
Methodological standard
Version
2.1
Published
01 Feb 2023
Last reviewed
01 Oct 2023
Next review
01 Oct 2026
Identifier
10.71829/cei.meth.1
Certainty
High
Cycle
2023 Q1
Category
Chromatographic purity

§5System suitability and acceptance criteria

§5.1System suitability

Table 1. System suitability criteria. A determination is reportable only where every criterion is met at the time of analysis.

ParameterCriterionWhat it establishes
Theoretical plates for the main peak≥ 2000Column efficiency
Peak symmetry factor (USP tailing)0.8 to 2.0Peak shape; a tailing factor above 2 for a basic peptide indicates inadequate ion pairing
Relative standard deviation of main-peak area, five replicate injections≤ 2.0 %Injection and detection repeatability
Resolution between the main peak and the nearest resolved impurity≥ 1.5Separation adequacy
Signal-to-noise ratio at the reporting threshold≥ 10Quantitation limit

§5.2Acceptance criteria

  • Purity is reported as determined; the Institute sets no universal acceptance limit because an appropriate limit depends on the compound and its intended use.
  • A determination is reportable only where all system-suitability criteria are met and the integration start time is stated.
  • A determination for a peptide whose main peak elutes with a retention factor below 1.0 is not reportable under this standard; use CEI-MS-19 for poorly retained analytes.
  • A purity figure reported without the method conditions in CEI-MS-01 §Apparatus is recorded by the Institute as not conformant.

§5.3Limitations

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.